October 6, 2025 – Jenny Gaffney, Vice President of Healthcare Economics & Reimbursement, will serve as a featured panelist at The MedTech Conference 2025, hosted by AdvaMed in San Diego. Gaffney will lend her expertise to a timely discussion on reimbursement for innovative medical technologies.
The panel discussion, “Navigating Medicare Administrative Contractors for Contractor-Priced Codes: Strategies for Success,” provides medtech innovators with critical insights into effectively engaging with Medicare Administrative Contractors (MACs) for contractor-priced codes. With evolving policies under the new administration, understanding the nuances of MACs’ decision-making processes is essential for ensuring timely and favorable coverage.
The panelists will discuss strategies for building strong relationships with MACs, aligning clinical evidence with contractor expectations, and navigating regional variations in policy implementation.
Session Details
- Date: Wednesday, October 8, 2025
- Time: 9:45–10:45 AM PT
- Location: Room 2, San Diego Convention Center
Panelists
- J.R. Murray, Managing Partner, Pan American Risk Management, LLC
- Jenny Gaffney, Vice President, Health Economics & Reimbursement, SafeHeal
- Harry Feliciano, MD, Principal & Medical Director, Decision Assist LLC
- Bonnie Handke, SVP, Patient Access, Reimbursement & Healthcare Economics, CVRx, Inc.
About SafeHeal™
SafeHeal SAS, headquartered in Paris, France, and its wholly-owned U.S. subsidiary, SafeHeal Inc., is a clinical-stage medical device company which develops Colovac, a device invented by a French digestive surgeon, Dr. Charam Khosrovani, to obviate the need for a digestive ostomy in patients undergoing colorectal surgery. Colovac is a flexible bypass sheath intended to reduce the contact of fecal content at the anastomotic site following colorectal surgery. The device is placed endoluminally and is fully reversible. The device remains in place for 10 days, until the body’s natural healing and tissue repair processes are complete, after which it is removed during an endoscopic procedure without the need for a second surgical intervention. This has the potential to enable patients to resume their normal lives without the stigma and complications associated with an ostomy procedure. Colovac is an investigational device limited by Federal (United States) law to investigational use. Colovac is already approved for use in the EU.